


International Point of Care | Fortis Life Sciences
Biotechnology Research • Toronto, Ontario, Canada • 21-50 Employees
Company overview
| Headquarters | 135 The West Mall #9, Etobicoke, Ontario M9C 1C2, CA |
| Phone number | +14168472744 |
| Website | |
| NAICS | 541714 |
| Employees | 21-50 |
| Socials |
Key Contacts at International Point of Care | Fortis Life Sciences
Joe Li Mba Pmp
Director, Manufacturing Operations
Anesley S Seevaratnam
Associate Director, Manufacturing, Lateral Flow Assay, And Quality Control
Victoria Scomazzon
Director Of Finance, Diagnostic Solutions
David Harris
Director Manufacturing And Process Development
International Point of Care | Fortis Life Sciences Email Formats
International Point of Care | Fortis Life Sciences uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@ipocdx.com), used 83.3% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@ipocdx.com | 83.3% |
{first initial}{last name} | jdoe@ipocdx.com | 16.7% |
About International Point of Care | Fortis Life Sciences
International Point of Care Incorporated (IPOC) products & services are fully integrated into Fortis Life Sciences. International Point of Care Incorporated (IPOC), based in Toronto, Canada, is a leading provider of innovative solutions for the in-vitro diagnostic industry and research and development community. With a strong focus on rapid point-of-care testing, we offer contract IVD manufacturing, lateral flow components (including Primecare blood separation membrane), and custom lyophilization services (including lyophilized beaded reagents, LBR) to meet the diverse needs of our global healthcare clientele. Our 36,000 sq ft manufacturing facility is an FDA-registered medical device establishment (cGMP-compliant) and ISO 13485:2016 certified. Our products and services include: • Fine biochemicals (recombinant proteins, monoclonal, and polyclonal antibodies) • Proprietary asymmetric blood separation membranes for application in point-of-care diagnostic tests • Contract lyophilization services to address commercial-scale demand • Contract manufacturing for lateral flow tests including formulation, production assembly, and packaging
International Point of Care | Fortis Life Sciences revenue & valuation
| Annual revenue | $1,600,000 |
| Revenue per employee | $62,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $5,200,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 21-50
Seniority
Employees
Employees by Department
International Point of Care | Fortis Life Sciences has 11 employees across 6 departments.
Departments
Number of employees
Funding Data
International Point of Care | Fortis Life Sciences has never raised funding before.
Frequently asked questions
4.8
40,000 users



